|
1
|
Dowling EC, Klabunde C, Patnick J and
Ballard-Barbash R; International Cancer Screening Network (ICSN).
Breast and cervical cancer screening programme implementation in 16
countries. J Med Screen. 17:139–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsuji W, Teramukai S, Ueno M, Toi M and
Inamoto T: Prognostic factors for survival after first recurrence
in breast cancer: a retrospective analysis of 252 recurrent cases
at a single institution. Breast Cancer. Apr 5–2012.(Epub ahead of
print).
|
|
3
|
Magee JA, Piskounova E and Morrison SJ:
Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer
Cell. 21:283–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu C, Cao X, Zhang Y, Xu H, Zhang R, Wu
Y, Lu P and Jin F: Co-expression of Oct-4 and Nestin in human
breast cancers. Mol Biol Rep. 39:5875–5881. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Louderbough JM and Schroeder JA:
Understanding the dual nature of CD44 in breast cancer progression.
Mol Cancer Res. 9:1573–1586. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ren L, Hong SH, Chen QR, Briggs J,
Cassavaugh J, Srinivasan S, Lizardo MM, Mendoza A, Xia AY, Avadhani
N, et al: Dysregulation of ezrin phosphorylation prevents
metastasis and alters cellular metabolism in osteosarcoma. Cancer
Res. 72:1001–1012. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bulut G, Hong SH, Chen K, Beauchamp EM,
Rahim S, Kosturko GW, Glasgow E, Dakshanamurthy S, Lee HS, Daar I,
et al: Small molecule inhibitors of ezrin inhibit the invasive
phenotype of osteosarcoma cells. Oncogene. 31:269–281. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Boldrini E, Peres SV, Morini S and de
Camargo B: Immuno-expression of Ezrin and CD44 in patients with
osteosarcoma. J Pediatr Hematol Oncol. 32:e213–e217. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu W, Rui H, Wang J, Lin S, He Y, Chen M,
Li Q, Ye Z, Zhang S, Chan SC, et al: Axin is a scaffold protein in
TGF-β signaling that promotes degradation of Smad7 by Arkadia. EMBO
J. 25:1646–1658. 2006.
|
|
12
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(in German).
|
|
13
|
Liu S, Clouthier SG and Wicha MS: Role of
microRNAs in the regulation of breast cancer stem cells. J Mammary
Gland Biol Neoplasia. 17:15–21. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Countercurrents Series and Narod SA. A
model for breast cancer risk based on stem-cell theory. Curr Oncol.
19:9–11. 2012.PubMed/NCBI
|
|
15
|
Liu CG, Lu Y, Wang BB, Zhang YJ, Zhang RS,
Lu Y, Chen B, Xu H, Jin F and Lu P: Clinical implications of stem
cell gene Oct-4 expression in breast cancer. Ann Surg.
253:1165–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gould KL, Bretscher A, Esch FS and Hunter
T: cDNA cloning and sequencing of the protein-tyrosine kinase
substrate, ezrin, reveals homology to band 4.1. EMBO J.
8:4133–4142. 1989.PubMed/NCBI
|
|
17
|
Hart SP, Rossi AG, Haslett C and
Dransfield I: Characterization of the effects of cross-linking of
macrophage CD44 associated with increased phagocytosis of apoptotic
PMN. PLoS One. 7:e331422012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang YY, Chen WL, Huang ZQ, Yang ZH, Zhang
B, Wang JG, Li HG and Li JS: Expression of the
membrane-cytoskeletal linker Ezrin in salivary gland adenoid cystic
carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
112:96–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hertweck MK, Erdfelder F and Kreuzer KA:
CD44 in hematological neoplasias. Ann Hematol. 90:493–508. 2011.
View Article : Google Scholar : PubMed/NCBI
|
